PriceSensitive

An independent survey confirms Else Nutrition products (TSXV:BABY) improve feeding-related disorders & symptoms

Consumer
TSXV:BABY
18 November 2021 13:30 (EDT)
Else Nutrition - CEO, Hamutal Yitzhak.

Source: Else Nutrition.

Else Nutrition Holdings (BABY) is pleased to announce results from an independent pilot study of its Plant-Based Nutrition for toddlers and kids.

The survey, conducted by third party global market research firm, GetWizer revealed that more than 75 per cent of parents whose children suffered from gastrointestinal problems (vomiting, reflux, spit-ups) while using another formula or supplement, reported an improvement after using Else Toddler or Else Kids.

The pilot study reveals major improvement in disorders and symptoms related to feeding problems including weight gain and GI-related symptoms.

Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition commented on the survey results.

“These results are extremely encouraging and provide independent validation as to the potentially significant difference clean label, whole plant food-based Else products are making with children across the country.”

“Improving lives and providing a real alternative to dairy for early childhood nutrition was the spark for starting Else and it is reassuring to see validation from moms that Else products are truly helping to make their families’ lives better,” she added.

Fully 90 per cent of parents surveyed said they would recommend using Else products to their friends.

The GetWizer pilot study was independently conducted via an online survey among randomly selected customers using Else Plant-Based Nutrition for Toddlers and Kids.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults.

Else Nutrition Holdings Inc. (BABY) is up 20.26 per cent on the day, trading at C$1.84 per share.

Related News